Which hospitalized pediatric patients should receive pharmacologic venous thromboembolism prophylaxis?
Existing guidelines suggest the use of pharmacologic VTE prophylaxis in certain hospitalized pediatric patients with conditions such as antiphospholipid syndrome or during specific treatments like chemotherapy for ALL, while other cases need individual assessment due to insufficient data.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-10-26
- DOI
- https://doi.org/10.5281/zenodo.23673509
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00